The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

One popular and affordable supplement that has shown some promise in helping with weight loss is berberine. In fact, some have called the supplement “nature’s Ozempic,” and with a month’s supply ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

Workouts at gyms to combat muscle loss caused by GLP-1 drugs are gaining traction, but do they differ from regular strength ...

At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles ...

For decades, the United States has led the world in pharmaceutical innovation — developing drugs that combat cancer, heart ...

Discover three undervalued biotech stocks with strong assets, solid cash reserves, and major catalysts ahead. Click for the ...

With a budget of up to $900,000, a deaf couple toured several Manhattan neighborhoods in search of a one-bedroom or two-bedroom near parks and subways. Here’s what they found. By Joyce Cohen ...

Our preview of the biggest English language Netflix Originals scheduled to drop globally.